Markel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), today announced the launch of its Clinical ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

Advanced analytics leverages machine learning (ML), statistical modeling, data mining and visualizations to empower ...

Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

Adds nine additional countries to the Company's ongoing pivotal Phase 3 trial; Authorization granted in all EU countries requested Enrollment and dosing underway in Phase 3 clinical trial (the "MIRACL ...

The RENEW Phase 2 trial will enroll up to 120 IPF patients with topline data expected in the first half of 2026 In the previously reported Phase 1b study, LTI-03 showed ...

A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and ...

Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) ...

Spectral is a clinical-stage medical device company focused on developing therapies for critical care, particularly septic ...